TNF Financial Statements From 2010 to 2025

TNFA Stock   1.19  0.04  3.48%   
TNF Pharmaceuticals, financial statements provide useful quarterly and yearly information to potential TNF Pharmaceuticals, investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on TNF Pharmaceuticals, financial statements helps investors assess TNF Pharmaceuticals,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting TNF Pharmaceuticals,'s valuation are summarized below:
Market Capitalization
3.1 M
Earnings Share
(10.48)
We have found one hundred twenty available fundamental trend indicators for TNF Pharmaceuticals,, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of TNF Pharmaceuticals, current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself next year. The current year's Market Cap is expected to grow to about 2.8 M. The current year's Enterprise Value is expected to grow to about 379.1 K
Check TNF Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TNF Pharmaceuticals,'s main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 550.1 K or Interest Income of 550.1 K, as well as many indicators such as Price To Sales Ratio of 0.0083, Dividend Yield of 0.54 or PTB Ratio of 0.22. TNF financial statements analysis is a perfect complement when working with TNF Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of TNF Pharmaceuticals, Correlation against competitors.
For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.

TNF Pharmaceuticals, Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets19.4 M16.1 M31.3 M
Slightly volatile
Short and Long Term Debt Total41.8 K44 K2.9 M
Slightly volatile
Other Current Liabilities2.2 M2.1 M1.3 M
Pretty Stable
Total Current LiabilitiesM5.7 M2.7 M
Slightly volatile
Total Stockholder Equity17.1 M11.5 M28.8 M
Slightly volatile
Property Plant And Equipment Net40.5 K42.7 K388.6 K
Slightly volatile
Accounts Payable1.9 M3.5 M1.1 M
Slightly volatile
Cash4.5 M2.4 M13.5 M
Slightly volatile
Non Current Assets Total10.1 M13.9 M4.1 M
Slightly volatile
Long Term Debt2.8 M3.2 M3.5 M
Slightly volatile
Cash And Short Term Investments4.2 M4.4 M26.2 M
Slightly volatile
Common Stock Shares Outstanding1.1 M1.8 M512.8 K
Slightly volatile
Short Term Investments1.9 MM12.8 M
Slightly volatile
Liabilities And Stockholders Equity19.4 M16.1 M31.3 M
Slightly volatile
Non Current Liabilities Total86 K90.5 K2.5 M
Slightly volatile
Capital Lease Obligations41.8 K44 K389.2 K
Slightly volatile
Other Current Assets705.8 KM269.5 K
Slightly volatile
Total Liabilities3.1 M5.9 M2.7 M
Slightly volatile
Property Plant And Equipment Gross40.5 K42.7 K388.6 K
Slightly volatile
Short and Long Term Debt56.5 K63.5 K69.3 K
Slightly volatile
Total Current AssetsM5.2 M27.5 M
Slightly volatile
Capital Stock470.8 K495.6 K6.5 M
Pretty Stable
Short Term Debt41.8 K44 K391.5 K
Slightly volatile
Common Stock1.7 K1.8 K131.1 M
Slightly volatile

TNF Pharmaceuticals, Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income550.1 K523.9 K101.5 K
Slightly volatile
Depreciation And Amortization7.8 M15.1 M3.2 M
Slightly volatile
Selling General Administrative7.8 M4.9 M6.9 M
Pretty Stable
Selling And Marketing Expenses2.5 M3.5 MM
Slightly volatile
Other Operating Expenses20 M19.7 M14.7 M
Slightly volatile
Research Development8.7 MM8.1 M
Slightly volatile
Total Operating Expenses20 M19.7 M14.7 M
Slightly volatile

TNF Pharmaceuticals, Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change To InventoryK1.1 K1.2 K
Slightly volatile
Stock Based Compensation4.3 M2.7 M3.6 M
Pretty Stable
Begin Period Cash Flow640.5 K674.2 K1.7 M
Pretty Stable
Change To Account Receivables34.3 K38.6 K42.1 K
Slightly volatile
Total Cash From Financing Activities11.5 M11.8 M29.2 M
Slightly volatile
End Period Cash Flow4.5 M2.4 M13.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.00830.00790.0044
Slightly volatile
Dividend Yield0.540.576.6191
Slightly volatile
Days Sales Outstanding42.2244.4486.363
Slightly volatile
Average Payables2.6 M2.4 M1.1 M
Slightly volatile
Capex To Depreciation0.320.330.26
Slightly volatile
Inventory Turnover2.53.362.3223
Slightly volatile
Days Of Inventory On Hand161112194
Slightly volatile
Payables Turnover0.05640.05941.3324
Slightly volatile
Average Inventory250.2 K263.4 K807.9 K
Slightly volatile
Research And Ddevelopement To Revenue0.310.570.5212
Pretty Stable
Capex To Revenue0.02610.03690.0322
Slightly volatile
Cash Per Share3.493.674.3 K
Slightly volatile
Days Payables Outstanding6.7 K6.4 K2.9 K
Slightly volatile
Income Quality3.072.921.3055
Slightly volatile
Intangibles To Total Assets0.560.530.3166
Slightly volatile
Current Ratio1.01.054.2362
Pretty Stable
Receivables Turnover11.4110.866.926
Slightly volatile
Graham Number24.0225.2886.3 K
Slightly volatile
Capex Per Share0.00.0190
Slightly volatile
Average Receivables623.3 K656.1 K830.2 K
Slightly volatile
Revenue Per Share2392518.7 K
Slightly volatile
Interest Debt Per Share0.03460.03647.1 K
Slightly volatile
Debt To Assets0.0030.00310.1573
Slightly volatile
Operating Cycle270147284
Slightly volatile
Days Of Payables Outstanding6.7 K6.4 K2.9 K
Slightly volatile
Ebt Per Ebit0.20.210.8614
Slightly volatile
Quick Ratio1.01.053.9043
Pretty Stable
Net Income Per E B T1.191.661.2807
Very volatile
Cash Ratio0.820.480.884
Pretty Stable
Days Of Inventory Outstanding161112194
Slightly volatile
Days Of Sales Outstanding42.2244.4486.363
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.790.90.9908
Slightly volatile
Fixed Asset Turnover10.1117.9614.6771
Slightly volatile
Debt Ratio0.0030.00310.1573
Slightly volatile
Price Sales Ratio0.00830.00790.0044
Slightly volatile
Asset Turnover0.470.250.3402
Slightly volatile

TNF Pharmaceuticals, Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.8 M2.7 M834.1 K
Slightly volatile

TNF Fundamental Market Drivers

Cash And Short Term Investments4.9 M

About TNF Pharmaceuticals, Financial Statements

TNF Pharmaceuticals, stakeholders use historical fundamental indicators, such as TNF Pharmaceuticals,'s revenue or net income, to determine how well the company is positioned to perform in the future. Although TNF Pharmaceuticals, investors may analyze each financial statement separately, they are all interrelated. For example, changes in TNF Pharmaceuticals,'s assets and liabilities are reflected in the revenues and expenses on TNF Pharmaceuticals,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in TNF Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue304.8 K320 K
Research And Ddevelopement To Revenue 0.57  0.31 
Capex To Revenue 0.04  0.03 
Revenue Per Share 251.34  238.77 
Ebit Per Revenue(4.62)(4.39)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:
Check out the analysis of TNF Pharmaceuticals, Correlation against competitors.
For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.48)
Return On Assets
(0.32)
Return On Equity
(2.98)
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.